Science Explorer Back to mapMap
Institution · EVRAZ (United Kingdom)

Most cited papers from EVRAZ (United Kingdom)

What are the most cited papers from EVRAZ (United Kingdom)?

The most cited paper from EVRAZ (United Kingdom) is "Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force" (Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al., 2016), with 755 citations. Next come "Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force" (486) and "Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group" (179).

Showing 50 of 60 papers. Every paper with more than 31 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force Praveen Thokala, Nancy J. Devlin, Kevin Marsh et al. · Value in Health Open access 2016 755
2 Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force Kevin Marsh, Maarten J. IJzerman, Praveen Thokala et al. · Value in Health Open access Mar 2016 486
3 Defining Patient Engagement in Research: Results of a Systematic Review and Analysis: Report of the ISPOR Patient-Centered Special Interest Group Rachel L. Harrington, Maya Hanna, Elisabeth M. Oehrlein et al. · Value in Health ReviewOpen access 23 May 2020 179
4 Prodromal symptoms of multiple sclerosis in primary care Giulio Disanto, Chiara Zecca, Sharon MacLachlan et al. · Annals of Neurology 9 May 2018 176
5 Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward Rob M.P.M. Baltussen et al. · Value in Health Open access 16 Oct 2019 170
6 Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach Kamal Desai, Swati B. Gupta, Erik R. Dubberke et al. · BMC Infectious Diseases Open access 17 Jun 2016 161
7 Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study Brian L. Bressler, Andres J. Yarur, Mark S. Silverberg et al. · Journal of Crohn s and Colitis Open access 25 Mar 2021 148
8 Data extraction for complex meta-analysis (DECiMAL) guide Hugo Pedder, Grammati Sarri, Edna Keeney et al. · Systematic Reviews Open access Dec 2016 131
9 Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent β-Thalassemia Marissa Blieden Betts, Patrick A. Flight, L. Clark Paramore et al. · Clinical Therapeutics Review 24 Dec 2019 112
10 The Use of MCDA in HTA: Great Potential, but More Effort Needed Kevin Marsh, Mark J. Sculpher, J. Jaime et al. · Value in Health Open access 22 Nov 2017 111
11 Cost-effectiveness of apixaban vs. current standard of care for stroke prevention in patients with atrial fibrillation Paul Dorian, Thitima Kongnakorn, Hemant M. Phatak et al. · European Heart Journal Open access 9 Feb 2014 99
12 Prevalence and incidence rates of cardiovascular, autoimmune, and other diseases in patients with psoriatic or psoriatic arthritis: a retrospective study using Clinical Practice Research Datalink Emily Edson‐Heredia, Baojin Zhu, Chloé Lefevre et al. · Journal of the European Academy of Dermatology and Venereology 28 Oct 2014 96
13 Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches Sally Mannix, Anne M. Skalicky, Dawn C. Buse et al. · Health and Quality of Life Outcomes Open access 6 Oct 2016 95
14 Prevalence of human papillomavirus in head and neck cancers in European populations: a meta-analysis Ṣẹ̀yẹ Abògúnr̀in, Gian Luca Di Tanna, Sam Keeping et al. · BMC Cancer ReviewOpen access Dec 2014 95
15 Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review Ṣẹ̀yẹ Abògúnr̀in, A.M. Mata Martín, Hannah Kurth et al. · Neuropsychiatric Disease and Treatment ReviewOpen access 2014 92
16 Epidemiological and clinical burden of EGFR Exon 20 insertion in advanced non-small cell lung cancer: A systematic literature review Heather F Burnett, Helena Emich, Chris Carroll et al. · PLoS ONE ReviewOpen access 8 Mar 2021 90
17 Assessing Rationality in Discrete Choice Experiments in Health: An Investigation into the Use of Dominance Tests Tommi Tervonen, Tabea Schmidt‐Ott, Kevin Marsh et al. · Value in Health Open access 6 Jun 2018 89
18 A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force John F. P. Bridges, Esther Wilhelmina de Bekker-Grob, Brett Hauber et al. · Value in Health Open access Feb 2023 87
19 Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation Gregory Y.H. Lip, Thitima Kongnakorn, Hemant M. Phatak et al. · Clinical Therapeutics Open access Feb 2014 87
20 Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model Alexia Kieffer, Matthieu Beuvelet, Aditya Sardesai et al. · The Journal of Infectious Diseases Open access 15 Aug 2022 85
21 Evaluation of multi-objective optimization approaches for solving green supply chain design problems Miłosz Kadziński, Tommi Tervonen, Michał K. Tomczyk et al. · Omega Open access 29 Jul 2016 77
22 Real-world data and the patient perspective: the PROmise of social media? Laura McDonald, Bill Malcolm, Sreeram V Ramagopalan et al. · BMC Medicine Open access 9 Jan 2019 75
23 Expanding Health Technology Assessments to Include Effects on the Environment Kevin Marsh, Michael Lee Ganz, John Y. Hsu et al. · Value in Health Open access 21 Jan 2016 73
24 Associations of Hemoglobin Levels With Health-Related Quality of Life, Physical Activity, and Clinical Outcomes in Persons With Stage 3-5 Nondialysis CKD Junichi Hoshino et al. · Journal of Renal Nutrition Open access 21 Jan 2020 70
25 Patient experiences with hypertrophic cardiomyopathy: a conceptual model of symptoms and impacts on quality of life Erica Zaiser, Amy J. Sehnert, Ashley Duenas et al. · Journal of Patient-Reported Outcomes Open access Dec 2020 64
26 Efficacy of Bimekizumab and Other Biologics in Moderate to Severe Plaque Psoriasis: A Systematic Literature Review and a Network Meta-Analysis April Wang Armstrong, Kyle R. Fahrbach, Craig L. Leonardi et al. · Dermatology and Therapy ReviewOpen access 7 Jul 2022 63
27 The value of diagnostic testing for parents of children with rare genetic diseases Deborah Anne Marshall, Karen V. MacDonald, Sebastian Heidenreich et al. · Genetics in Medicine Open access 25 Jun 2019 63
28 The humanistic burden of myasthenia gravis: A systematic literature review Deborah F. Gelinas, Sara Parvin-Nejad, Glenn A Phillips et al. · Journal of the Neurological Sciences ReviewOpen access 21 Apr 2022 61
29 Oral corticosteroid prescription patterns for asthma in France, Germany, Italy and the UK Trung Nam Tran, Elizabeth G. King, Rajiv Sarkar et al. · European Respiratory Journal Open access 12 Mar 2020 60
30 Advantages and disadvantages of discrete-event simulation for health economic analyses J. Jaime, Jörgen Möller · Expert Review of Pharmacoeconomics & Outcomes Research Open access 11 Mar 2016 57
31 Use of Patient-Reported Experience Measures in Pediatric Care: A Systematic Review Sumedh Bele, Lorynn Teela, Muning Zhang et al. · Frontiers in Pediatrics ReviewOpen access 20 Dec 2021 55
32 Co-creation of practical “how-to guides” for patient engagement in key phases of medicines development—from theory to implementation DAVID LEWIS FELDMAN et al. · Research Involvement and Engagement Open access 23 Aug 2021 54
33 MCDA swing weighting and discrete choice experiments for elicitation of patient benefit‐risk preferences: a critical assessment Tommi Tervonen, Heather L. Gelhorn, Sumitra Sri Bhashyam et al. · Pharmacoepidemiology and Drug Safety 11 Jul 2017 54
34 Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain Carlos Escobar, Beatriz Palacios, Luis Varela et al. · Journal of Clinical Medicine Open access 2 Sep 2022 51
35 Patient-Reported Outcomes in Chronic Heart Failure Mitchell A. Psotka, Robyn von Maltzahn, Milena Anatchkova et al. · JACC Heart Failure Open access 7 Jul 2016 50
36 Exploring the effect of vitamin D 3 supplementation on the anti-EBV antibody response in relapsing-remitting multiple sclerosis Linda Rolf, Anne‐Hilde Muris, Amandine Mathias et al. · Multiple Sclerosis Journal Open access 21 Jul 2017 48
37 Comparison of major bleeding risk in patients with non-valvular atrial fibrillation receiving direct oral anticoagulants in the real-world setting: a network meta-analysis Steven Bruce Deitelzweig, Caroline Farmer, Xuemei Luo et al. · Current Medical Research and Opinion 30 Nov 2017 47
38 Heuristics for prioritizing pair-wise elicitation questions with additive multi-attribute value models Krzysztof Ciomek, Miłosz Kadziński, Tommi Tervonen · Omega 29 Sep 2016 47
39 Entropy-optimal weight constraint elicitation with additive multi-attribute utility models Gert van Valkenhoef, Tommi Tervonen · Omega Open access 4 Nov 2015 47
40 Psychometric Evaluation of a Novel Instrument Assessing the Impact of Migraine on Physical Functioning: The Migraine Physical Function Impact Diary Ariane K. Kawata, Ray Hsieh, Randall H. Bender et al. · Headache The Journal of Head and Face Pain 30 Aug 2017 46
41 Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force Tommi Tervonen, Jorien Veldwijk, Katherine A. Payne et al. · Value in Health Open access 31 Mar 2023 45
42 Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013 Mireia Raluy-Callado, Dimitra Lambrelli, Sharon MacLachlan et al. · International Journal of COPD Open access May 2015 44
43 Treatment Preference Among People With Cystic Fibrosis Rory A. Cameron, Daniel Office, Jessie Matthews et al. · CHEST Journal Open access 19 Jul 2022 43
44 Patient-Reported Outcomes and Economic Burden of Adults with Sickle Cell Disease in the United States: A Systematic Review Soyon Lee, Diana K. Vania, Menaka Bhor et al. · International Journal of General Medicine ReviewOpen access Jul 2020 42
45 Patient Preferences for Multi-Cancer Early Detection (MCED) Screening Tests Heather L. Gelhorn, Melissa Ross, Anuraag R. Kansal et al. · Patient Open access 17 Jul 2022 41
46 Heuristics for selecting pair-wise elicitation questions in multiple criteria choice problems Krzysztof Ciomek, Miłosz Kadziński, Tommi Tervonen · European Journal of Operational Research 14 Apr 2017 41
47 Recurrence Rates and Pharmacological Treatment for Hemorrhoidal Disease: A Systematic Review Varut Lohsiriwat, Parvez Sheikh, Robert Bandolon et al. · Advances in Therapy ReviewOpen access 4 Nov 2022 39
48 Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review Ulf Helwig, Michael R. Mross, Stefan Schubert et al. · BMC Gastroenterology Open access 8 Jul 2020 39
49 Evaluating the Psychometric Properties of the Migraine Functional Impact Questionnaire (MFIQ) Ariane K. Kawata, Asha Hareendran, Shannon Shaffer et al. · Headache The Journal of Head and Face Pain Open access 5 Jun 2019 38
50 Benefit–Risk or Risk–Benefit Trade-Offs? Another Look at Attribute Ordering Effects in a Pilot Choice Experiment Sebastian Heidenreich, Andrea Phillips-Beyer, Bruno Flamion et al. · Patient 11 Nov 2020 37

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.